Ranitidine effervescent and famotidine wafer in the relief of episodic symptoms of gastro-oesophageal reflux disease

Scandinavian Journal of Gastroenterology

Volumn 32, Issue 6, 1997, Pages 513-518

  Engzelius, J M ^b   Solhaug, J H ^a   Knapstad, L J ^c   Kjaersgaard P ^c  

^a DIAKONHJEMMET HOSPITAL   (Norway)

^b Nesbru Legesenter   (Norway)

^c GLAXOSMITHKLINE   (United States)

Author keywords

Gastro oesophageal reflux; H2 antagonists; Treatment outcome

Indexed keywords

FAMOTIDINE; RANITIDINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; EFFERVESCENT TABLET; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TABLET FORMULATION; TREATMENT OUTCOME;

EID: 0030837399     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365529709025091     Document Type: Article

References (12)

1. Johnsson F, Joelsson B, Gudmundsson K, Greif L. Symptoms and endoscopie findings in the diagnosis of gastro-oesophageal reflux disease. Scand J Gastroenterol 1987;22:714-8.
2. Jones RH, Lydeard SE, Hobbs FD, Kenkre JE, Williams EI, Jones SJ, et al. Dyspepsia in England and Scotland. Gut 1990; 31:401-5.
3. Johansson K-E, Ask P, Boeryd B, Fransson S-G, Tibbling L. Oesophagitis, signs of reflux and gastric acid secretion in patients with symptoms of gastro-oesophageal reflux disease. Scand J Gastroenterol 1986;21:837-47.
4. Graham DY, Smith JL, Patterson DJ. Why do apparently healthy peuple use antacid tablets? Am J Gastroenterol 1983;78:257-60.
5. Devis G, De Rop H, Du Ville L, Van Avermaet S, Reynaert R, Michotte Y. Rapid absorption and high plasma concentrations with the ranitidine effervescent formulation results in a very quick onset of action on the intragastric pH in volunteers [abstract P13]. Scand J Gastroenterol 1993;28 Suppl 197:70.
6. Smout AJPM, Jonkman JHG, Peeters PAM, De Bruin H. Effect of an evening dose of regular and effervescent formulations of ranitidine and cimetidine on intragastric pH in healthy volunteers. Aliment Pharmacol Ther 1995;9:51-6.
7. Altman DG. Practical statistics for medical research. London: Chapman & Hall; 1995:241-65.
8. Altman DG. Practical statistics for medical research. London: Chapman & Hall; 1995:371-85.
9. Morris AI. Clinicians's manual on gastro-oesophageal reflux disease. London: Current Science; 1994. p. 23-7.
10. Tytgat GNJ, Bianchi Porro G, Feussner H, Pace F, Richter JE, Siewert JR. Long-term strategy for the treatment of gastro-oesophageal reflux disease. Gastroenterol Int 1991;4:21-32.
11. Hedenström H, Alm C, Kraft M, Grahnén A. Intragastric pH after administration of single doses of effervescent ranitidine. omeprazole capsules und famotidine fast dissolving tablets to healthy volunteers. Scand J Gastroenterol 1995;30 Suppl 209: 129.
12. Arnestad JS, Kleveland PM, Waldum HL. Faster and more consistent increase of intragastric pH with Zantac effervescent tablets than with Lanzo enterocapsules. Scand J Gastroenterol 1996;31 Suppl 217:23.